Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Broder

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
Current Molecular Medicine|December 27, 2005
Hendra and Nipah viruses: pathogenesis and therapeuticsBryan T Eaton, Christopher C Broder, Lin-Fa Wang
Advances in Experimental Medicine and Biology|July 26, 2013
Paramyxovirus entryKatharine N Bossart, Deborah L Fusco, Christopher C Broder
Cell Insight|February 19, 2025
Cedar virus biology and its applications as a surrogate for highly pathogenic henipavirusesAhmad Jawad Sabir, Lijun Rong, Christopher C Broder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2011
Pillars article: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996. 272: 872-877Yu Feng, Christopher C Broder, Paul E Kennedy, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2009
Preparation of recombinant viral glycoproteins for novel and therapeutic antibody discoveryYee-Peng Chan, Lianying Yan, Yan-Ru Feng, et al.
Nature Reviews. Microbiology|December 17, 2005
Hendra and Nipah viruses: different and dangerousBryan T Eaton, Christopher C Broder, Deborah Middleton, et al.
Viruses|April 4, 2012
Henipavirus mediated membrane fusion, virus entry and targeted therapeuticsDeborah L Steffen, Kai Xu, Dimitar B Nikolov, et al.
Vaccine|November 6, 2010
Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression systemGabriel N Defang, Dimple Khetawat, Christopher C Broder, et al.
Viruses|February 22, 2014
Recent observations on Australian bat lyssavirus tropism and viral entryDawn L Weir, Edward J Annand, Peter A Reid, et al.
The Journal of General Virology|February 6, 2026
Screening of FDA-approved drugs using a recombinant Cedar virus to improve treatment options for Nipah virus infectionEmily Clayton, Moushimi Amaya, Dung Nguyen, et al.
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
Current Molecular Medicine|December 27, 2005
Hendra and Nipah viruses: pathogenesis and therapeuticsBryan T Eaton, Christopher C Broder, Lin-Fa Wang
Advances in Experimental Medicine and Biology|July 26, 2013
Paramyxovirus entryKatharine N Bossart, Deborah L Fusco, Christopher C Broder
Cell Insight|February 19, 2025
Cedar virus biology and its applications as a surrogate for highly pathogenic henipavirusesAhmad Jawad Sabir, Lijun Rong, Christopher C Broder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2011
Pillars article: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996. 272: 872-877Yu Feng, Christopher C Broder, Paul E Kennedy, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2009
Preparation of recombinant viral glycoproteins for novel and therapeutic antibody discoveryYee-Peng Chan, Lianying Yan, Yan-Ru Feng, et al.
Nature Reviews. Microbiology|December 17, 2005
Hendra and Nipah viruses: different and dangerousBryan T Eaton, Christopher C Broder, Deborah Middleton, et al.
Viruses|April 4, 2012
Henipavirus mediated membrane fusion, virus entry and targeted therapeuticsDeborah L Steffen, Kai Xu, Dimitar B Nikolov, et al.
Vaccine|November 6, 2010
Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression systemGabriel N Defang, Dimple Khetawat, Christopher C Broder, et al.
Viruses|February 22, 2014
Recent observations on Australian bat lyssavirus tropism and viral entryDawn L Weir, Edward J Annand, Peter A Reid, et al.
The Journal of General Virology|February 6, 2026
Screening of FDA-approved drugs using a recombinant Cedar virus to improve treatment options for Nipah virus infectionEmily Clayton, Moushimi Amaya, Dung Nguyen, et al.
Pageof 19